AFP and hepatocellular carcinoma: An important point was discussed in our results; AFP status was higher in the majority of the BCL9 CN gain group, as AFP is the most common marker for HCC diagnosis [62]; therefore, we speculate that there is a vital role of AFP to be taken into consideration as an influencer with BCL9 CNV in HCC patients, but further work is needed to verify our hypothesis.